Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / COM
-
Number of holders
-
152
-
Total shares
-
54.7M
-
Shares change
-
+3.92M
-
Total reported value, excl. options
-
$262M
-
Value change
-
+$16.5M
-
Put/Call ratio
-
1.25
-
Number of buys
-
67
-
Number of sells
-
-74
-
Price
-
$4.80
Significant Holders of CLOVIS ONCOLOGY INC - COM (CLVSQ) as of Q4 2020
178 filings reported holding CLVSQ - CLOVIS ONCOLOGY INC - COM as of Q4 2020.
CLOVIS ONCOLOGY INC - COM (CLVSQ) has 152 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54.7M shares
.
Largest 10 shareholders include STATE STREET CORP (14.5M shares), BlackRock Inc. (6.85M shares), VANGUARD GROUP INC (6.39M shares), Palo Alto Investors LP (4.47M shares), ARMISTICE CAPITAL, LLC (2.26M shares), CITADEL ADVISORS LLC (1.86M shares), Point72 Asset Management, L.P. (1.8M shares), GEODE CAPITAL MANAGEMENT, LLC (1.35M shares), MORGAN STANLEY (1.09M shares), and NORTHERN TRUST CORP (973K shares).
This table shows the top 152 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.